Intracerebral administration of Interleukin-12 (IL-12) and IL-18 modifies the course of mouse scrapie

BACKGROUND: Prion diseases are characterised by a neurodegenerative pattern in which the function of immune system remains still elusive. In the present study, we evaluate if an exogenous treatment with Interleukin-12 (IL-12) and IL-18, able to activate microglia, is able to affect scrapie pathogene...

Descripción completa

Detalles Bibliográficos
Autores principales: Pasquali, Paolo, Nonno, Romolo, Mandara, Maria Teresa, Di Bari, Michele Angelo, Ricci, Giovanni, Petrucci, Paola, Capuccini, Silvia, Cartoni, Claudia, Macrì, Agostino, Agrimi, Umberto
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1769363/
https://www.ncbi.nlm.nih.gov/pubmed/17192191
http://dx.doi.org/10.1186/1746-6148-2-37

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1769363/
https://www.ncbi.nlm.nih.gov/pubmed/17192191
http://dx.doi.org/10.1186/1746-6148-2-37

Ejemplares similares